Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qiangfu Biotech is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the field of Antibody-Drug Conjugates (ADCs). Founded by industry veterans with extensive experience in bioconjugation, the company provides integrated services including linker-payload synthesis, antibody production, and drug product manufacturing. Qiangfu operates state-of-the-art facilities in Shanghai designed to support the rapid development of complex biotherapeutics from discovery to clinical stages. By offering a "one-stop" solution, the company helps global pharmaceutical and biotech partners overcome the technical challenges associated with ADC chemistry and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qiang Fu.